Descrição
Retatrutide is a triple agonist targeting the GIP, GLP-1 and glucagon receptors, studied in metabolic, glucose-regulation and energy-expenditure research models. For Research Use Only (RUO). Not for human or veterinary use. Not for diagnostic or therapeutic purposes.

Avaliações
Não há avaliações ainda.